Fund Overlap
See which holdings any two equity ETFs have in common, along with top differences in exposure.

OVERLAP
14%
OVERLAP
BY WEIGHT
12
# OF OVERLAPPING
HOLDINGS
BBP
65
HOLDINGS
20%
ALSO IN IDNA
IDNA
44
HOLDINGS
32%
ALSO IN BBP
SECTOR DRIFT (BBP minus IDNA)
OVERLAPPING HOLDINGS
Top 5 only shown here. Please log-in or sign up for a Basic (Free) membership to view the complete list.
Company | Weight in BBP |
Weight in IDNA |
Overlap | |
---|---|---|---|---|
EXELIXIS INC | 1.8% | 3.5% | 1.8% | |
BIOCRYST PHARMACEUTICALS INC | 1.7% | 3.0% | 1.7% | |
INCYTE CORP | 1.6% | 4.8% | 1.6% | |
REGENERON PHARMACEUTICALS | 1.6% | 4.6% | 1.6% | |
NOVAVAX INC | 1.5% | 2.5% | 1.5% |
BBP Overweight Relative to IDNA
INTRA-CELLULAR THERAPIES INC | 2.6% | |
BEIGENE LTD. SPONSORED ADR | 2.3% | |
ZAI LAB LTD. UNSPONSORED ADR | 2.2% | |
SAGE THERAPEUTICS INC | 2.2% | |
AXSOME THERAPEUTICS, INC. | 2.1% | |
GILEAD SCIENCES INC | 2.1% | |
SPRINGWORKS THERAPEUTICS, INC. | 2.1% | |
HALOZYME THERAPEUTICS INC | 2.1% | |
TG THERAPEUTICS INC | 2.1% | |
AMGEN INC | 2.0% |
BBP Underweight Relative to IDNA
GENMAB A/S | -4.3% | |
ASTRAZENECA PLC | -4.3% | |
MERCK & CO. INC. | -4.3% | |
TAKEDA PHARMACEUTICAL CO LTD | -4.1% | |
ARCELLX, INC. | -4.1% | |
SANOFI-AVENTIS | -4.0% | |
ROCHE HOLDING LTD | -3.9% | |
GSK PLC | -3.8% | |
CELCUITY INC. | -3.5% | |
TWIST BIOSCIENCE CORP. | -3.5% |